NEW YORK (GenomeWeb News) – The Center for Medicare Services is beginning to take a closer look at genetic tests and will consider if some of these molecular tests should be approved for coverage under the program.

CMS will review evidence on genetic tests, assess their preventive value, and will consider gene expression and pharmagoconemic tests for coverage decisions, according to CMS's Chief Medical Officer, Barry Straube, who spoke recently at a Department of Health and Human Services meeting in Washington, DC.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: co-evolutionary signatures of insect hosts and bacterial symbionts, distinct transcript isoforms of high-grade ovarian cancer, and more.

Adam Rutherford discusses genetic genealogy at the Guardian.

Portions of the US 21st Century Cures Act are raising some safety concerns.

David Dobbs writes at Buzzfeed that genomics has delivered little on its promises.